Health

Pfizer Covid-19 vaccine will purchased by Biden administration in 105 million doses

The US Department of Health and Human Services said on Wednesday that the Biden administration has agreed to buy 105 million doses of Pfizer’s Covid-19 vaccine. The contract, which is for vaccinations in the fall, totals $3.2 billion and includes “options for up to 300 million doses,” according to an agency news release. The order,…

Keep Reading
Business

Two Covid vaccination doses aren’t ‘enough for omicron,’ according to Pfizer’s CEO

On Monday, Pfizer CEO Albert Bourla indicated that two doses of the company’s vaccine may not provide adequate protection against infection by the omicron Covid form, and that the initial shots have lost part of their efficacy in avoiding hospitalisation. Bourla stressed the importance of a third shot to increase people’s protection against omicron in…

Keep Reading
Business

Pfizer’s anti-COVID tablet receives emergency approval from Health Ministry

Paxlovid, a COVID-19-fighting antiviral oral medication developed by Pfizer, received emergency approval from the Health Ministry on Sunday. Israel has negotiated a deal with Pfizer for the medicine, according to the government, and a shipment is anticipated to arrive in the coming days. The US Food and Drug Administration (FDA) granted emergency approval for the…

Keep Reading
Business

Pfizer say Covid-19 may become endemic by 2024

According to Pfizer officials, Covid will become an endemic disease as early as 2024, meaning the virus would convert from a worldwide emergency to a persistent presence causing regional outbreaks around the world, similar to the flu. During a Friday investor call, Nanette Cocero, worldwide head of Pfizer Vaccines, said, “We believe Covid will transition…

Keep Reading
Business

Biden administration purchase 10M courses of Pfizer’s Covid treatment pill in $5 billion deal

President Joe Biden announced on Thursday that the United States has purchased 10 million courses of Pfizer’s Covid treatment tablet, an oral antiviral medicine that was shown in a clinical trial to be very successful in reducing hospitalisation among high-risk patients. Paxlovid, the tablet, has the potential to revolutionise the fight against the virus by…

Keep Reading
Business

Pfizer and BioNTech’s Covid vaccine is protected and generates ‘robust’ immune response in kids ages 5 to 11

Pfizer and BioNTech’s Covid-19 vaccine is safe and generates a “robust” immune response in a clinical trial of children ages 5 to 11, the drugmakers reported in a press release Monday. The organizations tested a two-dose regimen of 10 micrograms — about a third the dosage utilized for teens and adults — directed three weeks…

Keep Reading
error: Content is protected !!